# Study of PXL01 Versus Placebo to Inhibit Adhesion Formation After Flexor Tendon Surgery

> **NCT01022242** · PHASE2 · COMPLETED · sponsor: **Pergamum AB** · enrollment: 138 (actual)

## Conditions studied

- Surgical Adhesions

## Interventions

- **DRUG:** PXL01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01022242
- **Lead sponsor:** Pergamum AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-05
- **Final completion:** 2013-02
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01022242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01022242, "Study of PXL01 Versus Placebo to Inhibit Adhesion Formation After Flexor Tendon Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01022242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*